Blog

Reliability as a Competitive Advantage: Metabolon’s Model for High-Uptime LC-MS Operations 

Thomas Houseman headshot with texture background

Metabolon is the global leader in metabolite identification and biological interpretation.  Using liquid chromatography–mass spectrometry (LC-MS) and our proprietary, industry-leading library, we generate high-quality metabolomics data across a broad range of sample matrices (blood, plasma, etc.) at an industrial scale, processing hundreds of thousands of samples annually. 

Delivering that scale with consistency requires more than analytical capability; it requires operational excellence.  Many laboratories operating similar LC-MS platforms experience rework rates above 10% due to ionization instability, calibration drift, and unplanned instrument faults.  Metabolon has built a performance management system that proactively controls instrument health and reduces workflow variability, lowering rework to approximately 3% while protecting uptime, throughput, and data quality. 

Building Predictable Performance into the Platform 

1) Method Harmonization to Reduce Variability and Speed Recovery 

Wherever feasible, Metabolon harmonizes LC-MS methods across platforms: 

  • Common column chemistry and formats 
  • Consistent temperature profiles 
  • Standardized gradient structures 

This limits the number of “moving parts” that can shift performance between instruments and runs.  It also shortens troubleshooting cycles by reducing method-to-method complexity, making it easier to isolate whether drift originates in chromatography, ion source behavior, or mass calibration. 

2) Daily System Suitability + QC Designed to Detect Drift Before It Becomes Rework 

Rather than waiting for trending failures to appear in downstream metrics, Metabolon relies on daily performance checks and robust quality controls intended to surface early signals of: 

  • Ionization instability 
  • Calibration drift 
  • Sensitivity changes 
  • Chromatographic shifts (e.g., retention time movement, peak shape degradation) 

This approach catches degradation early—before it triggers batch impact, re-runs, or avoidable investigation effort. 

3) Volume-Based Preventive Maintenance (PM) Instead of Calendar-Only PM 

Instrument utilization drives wear.  Metabolon uses instrument volume to determine PM cadence: 

  • Higher sample volume → more frequent cleaning, more frequent seal replacement, and more frequent vendor PM 
  • Continuous-use systems → ongoing health monitoring and tighter intervention thresholds 

This workload-aware scheduling prevents performance decay that accumulates silently under high throughput and reduces the “surprise failure” mode that creates downtime and rework. 

Engineering Consistency Through Automation 

Automation targets steps with the highest human-driven variance and the greatest downstream impact on LC-MS stability. By automating sample preparation steps prone to operator variability, including pipetting and sample transfers, Metabolon improves repeatability and reduces batch-to-batch variation. 

In practice, tighter sample preparation consistency enables data-driven predictability of impact on instrument performance and appropriate preventative procedures: 

  • Matrix load delivered to the system; for example, liver and brain samples reduce column lifetime compared to plasma or urine, so more frequent column changes are required 
  • Ion source cleanliness and ionization behavior; for example, high salinity samples have a higher impact on source cleanliness, so the source must be cleaned before the analysis of additional samples 
  • Day-to-day sensitivity and response stability; larger projects need to have additional QC metrics to monitor instrument performance over time  

The result is fewer drift-driven interventions and fewer forced re-runs. 

KPI-Driven Operations: Turning Data into Early Intervention 

Dashboards track business-critical KPIs that connect instrument behavior to operational outcomes.  The goal isn’t just reporting—it’s trend detection and root-cause targeting. 

By trending rework and downtime drivers over time, teams can: 

  • Identify recurring failure modes 
  • Link issues to instruments, methods, or workload patterns 
  • Prioritize corrective actions that reduce repeat events 

This is how performance management stays predictive rather than reactive. 

Uptime Strategy: Maintenance Depth, Spares, and Rapid Response 

Maintenance Beyond Baseline Recommendations 

To maximize availability under high utilization, Metabolon often exceeds manufacturer-recommended PM intervals and supplements them with additional vendor preventive maintenance throughout the year.  The objective is to keep high-use systems operating in a stable window rather than cycling between “good” and “recovering.” 

On-site Critical Spare Parts and Consumables to Minimize Extended Downtime 

A limited inventory of critical spare parts and consumables reduces the risk of downtime when failures occur.  When lead times for needed parts are the dominant driver of outage duration, on-site spares materially improve time-to-recovery. 

Fast Troubleshooting with Remote Diagnostics 

When issues arise, analysts are trained to respond promptly, and remote diagnostics tools enable real-time troubleshooting—helping teams triage quickly, reduce uncertainty, and return instruments to service faster. 

Powered by People: Standard Work and Cross-Functional Review 

Behind technical success is a culture that treats performance as a shared responsibility.  Regular huddles bring together analysts, support staff, and QA specialists to review performance trends, align on corrective actions, and reinforce standard work.  This routine cross-functional cadence helps prevent small signals from becoming recurring root causes. 

The Operational Impact 

Keeping rework low and instrument uptime high creates compounding business benefits: 

  • Higher throughput without sacrificing quality 
  • Shorter turnaround times and more predictable scheduling 
  • Increased confidence in data consistency 

Most importantly, scientists spend less time recovering from avoidable variability and more time delivering accurate, actionable metabolomic insights that help partners advance human health.  By combining harmonized methods, workload-based preventive maintenance, automation, and KPI-driven continuous improvement, Metabolon has built a scalable operating model for LC-MS excellence—one that advances discovery, sample after sample.

Thomas Houseman
Tom enables process efficiency and capability across Metabolon laboratory testing and operations, and at Metabolon facilities.

Topics

Share this article

GET STARTED

Talk with an expert

Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research. Find our contact details are here.

Find us on:

Talk with a Metabolomics expert

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.